Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

CARA Cara Therapeutics Inc

0,7272

-0,0329 (-4,33%)

11 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Cara Therapeutics Charts.

Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Cara Therapeutics Charts.

News Cara Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Montag 6 Mai 2024 (5 Tage vor) • Edgar (US Regulatory)

Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
Montag 6 Mai 2024 (5 Tage vor) • GlobeNewswire Inc.

Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Dienstag 2 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
Donnerstag 7 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
Montag 4 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 12 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Cara Therapeutics Inc News-Artikel

MPM Corporeos ON

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen